MicroPort CardioFlow Medtech Corporation (2160.HK) HKSE
1.67
-0.01(-0.60%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.67
-0.01(-0.60%)
Currency In HKD
Address
Zhangjiang Hi-Tech Park
Shanghai, 201203
China
Phone
86 21 3895 4600
Sector
Healthcare
Industry
Medical - Devices
Employees
430
First IPO Date
February 04, 2021
| Name | Title | Pay | Year Born |
| Ruinian Zhang | CEO, GM & Executive Director | 1.79M | 1964 |
| Philippe Wanstok | President & Executive Director | 156,746 | 1964 |
| Paul Vodden | Chief Financial Officer | 0 | 1966 |
| Xiaoming Zhu | Chief Operating Officer | 0 | 1968 |
| Alice Flacco | Executive VP & General Counsel | 0 | 1985 |
| Xiangmei Li | Joint Company Secretary | 0 | N/A |
| Lok Yee Chan | Joint Company Secretary | 0 | 1990 |
MicroPort CardioFlow Medtech Corporation, a medical device company, researches, develops, and commercializes transcatheter and surgical solutions for structural heart diseases in the People's Republic of China. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set to target aortic, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company was founded in 2010 and is headquartered in Shanghai, China.